- About IMB
The University of Queensland’s Institute for Molecular Bioscience (IMB), which is based at the Queensland Bioscience Precinct, is one of Asia-Pacific’s leading life sciences research institutes.
Established in 2000 as UQ’s first research institute, IMB is a multidisciplinary scientific research institute committed to improving quality of life by pursuing discoveries in medical genomics, drug discovery and biotechnology.
IMB’s 500 researchers, postgraduate students and support staff work in partnership with their academic, industry and clinical colleagues around the world to advance knowledge in the institute’s seven impact areas: cancer, pain, childhood diseases, infection and inflammation, diabetes and obesity, agriculture, and clean energy.
Our mission is to drive the bioeconomy and to create better health.
Our vision is to be a life sciences institute with a global impact.
IMB scientists conduct research across these priority areas in three major research divisions:
- Chemistry and Structural Biology Division
- Genomics of Development and Disease Division
- Cell Biology and Molecular Medicine Division
By investigating how we grow and develop at the genetic, molecular, cellular and organ levels, IMB researchers can better understand the development processes and pathways involved in human and animal health and disease.
The institute also has the technical capacity to translate its new knowledge into drugs, diagnostics and technologies to more effectively prevent, detect and treat disease; and pursue opportunities in a range of biotechnology applications for health, industry and the environment.
The Institute's research outcomes are protected and commercialised by the University-owned technology transfer group UniQuest.
|About IMB section|